If you are looking to have a rational discussion about the value of pharmaceuticals rather than just the cost, you should avoid Vermont. Sen. Bernie Sanders (I-Vt.) plans to hold a hearing on the high cost of drugs, especially those for hepatitis C, which have revolutionized the treatment of the … Continue reading
Dr. Gilbert Ross in The Observer, October 21, 2014
This Thursday, our city’s legislators will discuss a proposal banning flavored nicotine liquids and flavorings said Continue reading
The attack on sugary sweetened beverages is back, as New York City Mayor Bill de Blasio has voiced his support for limiting the size of sugary drinks. Although de Blasio has not yet decided how he is going to approach this Continue reading
An op-ed in Forbes.com wonders why clean, safe, zero-carbon-footprint nuclear energy has so few friends in high places these days. ACSH advisor and co-author of our publication on nuclear energy has some thoughts, but no answers. Continue reading
Dr. Gilbert Ross in The Parliament Magazine, October 13, 2014.
The EU’s five-year process of revising the tobacco products directive (TPD) has resulted in a nearly-unmitigated disaster. Eschewing at every opportunity science-based (or even rational) policy, a conflicted, unaccountable bunch of commissars, (I mean commissioners) working in secret and in concert with like-minded petty Continue reading
r. Gilbert Ross in the EUReporter, October 13, 2014.
The EU’s five-year process of revising the Tobacco Products Directive (TPD) has resulted in a nearly-unmitigated disaster. Eschewing at every opportunity science-based (or even rational) policy, a conflicted, Continue reading
As we mentioned earlier this week, ACSH’s Dr. Josh Bloom is not a big fan of how the CDC is attempting to control the spread of Ebola.
He has written an op-ed on Science 2.0, entitled “Preventing Ebola: Screen — Or Screen Door?” which reflects this rather clearly. Continue reading
A surprising new front in the war against fracking: Texas, the heart of the fossil fuel industry. Although the anti-frackers (?fractavists) are as scientifically clueless as their New York State fellow-activists, the upcoming vote may be close. Continue reading
Although the actual impact of Ebola on the world so far is minuscule, it has been the top news story much of the time over the past few weeks.
We at ACSH are no strangers to media scares and frenzies, and it is clear that this is one of the main drivers here. But it is not the only one. Continue reading
The Biotechnology Industry Organization (BIO) has taken issue with a recent 60 Minutes piece about the high price of new oncology drugs.
The BIO response was “It is unfortunate that CBS has chosen to attack the price of specialty cancer medications while ignoring the value created by these drugs for patients and the health care system. Cancer patients today are able to live longer and enjoy a higher quality of life than ever before thanks to medicines made by biopharmaceutical research companies.” Continue reading